| Title: |
2022-RA-941-ESGO CEBOC, a single-arm phase II trial to evaluate the safety of cediranib in the prevention of bowel perforation in platinum resistant ovarian cancer |
| Authors: |
Murphy, Alexander; Porter, Catharine; White, Ann; Irving, Alys; Ray, Ruby; Casbard, Angela; Madden, Tracie-Ann; Mahmood, Reem; Morgan, Robert; Pugh, Julia; Wheeler, Chelsey; Roberts, Victoria; Arnetoli, Giorgio; Salih, Zena; Hasan, Jurjees; Mitchell, Claire; Clamp, Andrew; Jayson, Gordon |
| Source: |
Ovarian cancer ; page A281.2-A282 |
| Publisher Information: |
BMJ Publishing Group Ltd |
| Publication Year: |
2022 |
| Document Type: |
conference object |
| Language: |
unknown |
| DOI: |
10.1136/ijgc-2022-esgo.599 |
| DOI: |
10.1136/ijgc-2022-ESGO.599 |
| Availability: |
https://doi.org/10.1136/ijgc-2022-esgo.599; https://syndication.highwire.org/content/doi/10.1136/ijgc-2022-ESGO.599 |
| Accession Number: |
edsbas.ED69E959 |
| Database: |
BASE |